Literature DB >> 12554528

Recombinant interferon alfa 2a in hepatic hemangiomatosis with congestive heart failure: a case report.

A Schiavetti1, M D De Pasquale, S Di Salvo, F Ventriglia, A Clerico.   

Abstract

A 45-day-old patient was admitted with dyspnea, hepatomegaly, tachycardia, holosystolic murmur in the precordial region, and continuous murmur at the right hypochondrium. Four cutaneous angiomas were noted. Instrumental examinations revealed congestive heart failure and multiple focal lesions in the liver with typical features of hemangiomas. The therapy with subcutaneous interferon-alfa-2a (IFN-alpha) was administered for 12 months with progressive regression of cutaneous hemangiomas, liver lesions, and cardiological alterations. IFN-alpha therapy was effective without any significant adverse effects.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554528     DOI: 10.1080/0880010390158676

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  3 in total

1.  Intralesional administration of interferon A for the management of severe haemangiomas.

Authors:  C Kaselas; G Tsikopoulos; G Papouis; V Kaselas
Journal:  Pediatr Surg Int       Date:  2006-12-15       Impact factor: 1.827

2.  The association of consumptive hypothyroidism secondary to hepatic hemangioma and severe heart failure in infancy.

Authors:  Suna Emir; Filiz Ekici; Mehmet Alper İkiz; Sadi Vidinlisan
Journal:  Turk Pediatri Ars       Date:  2016-03-01

3.  Pancreaticoduodenal and choledochal hemangiomatosis with vascular variation in a child: a rare disease with challenge starts from diagnosis-a case report.

Authors:  Daguang Tian; Hong Zhu; Xiaoping Wei
Journal:  World J Surg Oncol       Date:  2022-09-07       Impact factor: 3.253

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.